856
Participants
Start Date
December 20, 2012
Primary Completion Date
December 10, 2024
Study Completion Date
December 10, 2024
Lecanemab 2.5 mg/kg
2.5 mg/kg biweekly (once every 2 weeks) administered as i.v. infusion
Lecanemab 5.0 mg/kg
5.0 mg/kg biweekly (once every 2 weeks) administered as i.v. infusion
Lecanemab 10 mg/kg
10 mg/kg biweekly (once every 2 weeks) administered as i.v. infusion.
Lecanemab 5.0 mg/kg
5.0 mg/kg monthly (once every 4 weeks) administered as i.v. infusion. All participants will receive biweekly infusions, participants will have placebo infusion alternating with BAN2401
Lecanemab 10 mg/kg
10 mg/kg monthly (once every 4 weeks) administered as i.v. infusion. All participants will receive biweekly infusions, participants will have placebo infusion alternating with BAN2401
Placebo
biweekly (once every 2 weeks) administered as i.v. infusion
Lecanemab 10 mg/kg
10 mg/kg biweekly (once every 2 weeks), once every 4 weeks (Q4W) or once every 3 months (Q3M) i.v. infusion.
Facility #1, New York
Facility #2, New York
Facility #1, Latham
Facility #1, Albany
Facility #1, Amherst
Facility #1, Rochester
Facility #2, Rochester
Facility #1, Abington
Facility #1, Jenkintown
Facility #1, Richmond
Facility #1, Charlotte
Facility #1, Decatur
Facility #2, Atlanta
Facility #1, Atlanta
Facility #1, Columbus
Facility #1, Orlando
Facility #1, Hallandale
Facility #1, Hialeah
Facility #1, Deerfield Beach
Facility #1, Miami
Facility #2, Miami
Facility #3, Miami
Facility #1, Miami Springs
Facility #1, Sunrise
Facility #1, Palm Beach Gardens
Facility #1, Boca Raton
Facility #1, Delray Beach
Facility #1, Lake Worth
Facility #1, Atlantis
Facility #2, Boca Raton
Facility #3, Tampa
Facility #1, Tampa
Facility #2, Tampa
Facility #1, St. Petersburg
Facility #1, Fort Myers
Facility #1, Naples
Facility #1, Bradenton
Facility #1, Ocala
Facility #1, Leesburg
Facility #2, Leesburg
Facility #1, Birmingham
Facility #1, Knoxville
Facility #1, Lexington
Facility #1, Centerville
Facility #1, Indianapolis
Facility #1, Elkhart
Facility #1, West Bloomfield
Facility #1, Farmington Hills
Facility #1, Lansing
Facility #1, Milwaukee
Facility #1, Elk Grove Village
Facility #1, Chicago
Facility #1, St Louis
Facility #1, Wichita
Facility #1, Oklahoma City
Facility #2, Oklahoma City
Facility #1, Dallas
Facility #1, Houston
Facility #1, San Antonio
Facility #2, San Antonio
Facility #3, San Antonio
Facility #1, Austin
Facility #1, Phoenix
Facility #1, Tucson
Facility #1, Los Angeles
Facility #2, Los Angeles
Facility #3, Los Angeles
Facility #1, Lomita
Facility #1, Los Alamitos
Facility #1, Carson
Facility #1, Long Beach
Facility #1, San Diego
Facility #1, Oxnard
Facility #2, Portland
Facility #1, Portland
Facility #1, Orange
Facility #1, The Villages
Facility #1, East Lansing
Facility #2, Dallas
Facility #1, Kentville
Facility #1, Kingston
Facility #2, London
Facility #1, Ottawa
Facility #1, Peterborough
Facility #1, Toronto
Facility #1, Greenfield Park
Facility #1, Montreal
Facility #1, Verdun
Facility #1, Québec
Facility #1, Strasbourg
Facility #1, Toulouse
Facility #1, Paris
Facility #1, Bron
Facility #1, Paris
Facility #1, Rennes
Facility #1, Villeurbanne
Facility #1, Gunzburg
Facility #1, Karlstadt am Main
Facility #1, Hanover
Facility #1, Mittweida
Facility #1, Hoppegarten
Facility #1, Berlin
Facility #2, Berlin
Facility #3, Berlin
Facility #1, Günzburg
Facility #1, Hamburg
Facility #1, Heidelberg
Facility #1, Leipzig
Facility #1, Mannheim
Facility #1, München
Facility #1, Tübingen
Facility #1, Brescia
Facility #1, Genova
Facility #1, Milan
Facility #1, Parma
Facility #1, Perugia
Facility #1, Pisa
Facility #1, Roma
Facility #2, Roma
Facility #3, Roma
Eisai Trial Site #1, Otake-shi
Eisai Trial Site #1, Himeji-shi
Eisai Trial Site #2, Himeji-shi
Eisai Trial Site #3, Himeji-shi
Eisai Trial Site #1, Kobe
Eisai Trial Site #1, Nishinomiya-shi
Eisai Trial Site #1, Kyoto
Eisai Trial Site #1, Kurashiki-shi
Eisai Trial Site #1, Osaka
Eisai Trial Site #1, Saitama-shi
Eisai Trial Site #1, Itabashi-ku
Eisai Trial Site #1, Shinjuku-ku
Eisai Trial Site #2, Shinjuku-ku
Facility #1, Amsterdam
Facility #1, Seongnam-si
Facility #1, Pusan
Facility #2, Seoul
Facility #3, Seoul
Facility #4, Seoul
Facility #1, Sant Cugat Del Vallés
Facility #1, Donostia / San Sebastian
Facility #1, Barakaldo
Facility #1, Alicante
Facility #1, Barcelona
Facility #1, Madrid
Facility #2, Madrid
Facility #1, Seville
Facility #1, Malmo
Facility #1, Mölndal
Facility #1, Stockholm
Facility #1, Uppsala
Facility #1, London
Facility #1, Isleworth
Facility #1, Glasgow
Facility #1, Bath
Facility #2, London
Facility #1, Swindon
Facility #1, Denver
Facility #1, New Haven
Facility #2, New Haven
Facility #1, Boston
Facility #2, Boston
Facility #1, Burlington
Facility #1, Newton
Facility #1, Ann Arbor
Facility #1, Eatontown
Facility #1, Toms River
Facility #1, East Providence
Facility #1, Bennington
Collaborators (1)
Biogen
INDUSTRY
Eisai Inc.
INDUSTRY